tradingkey.logo

Hepion Pharma In-Licenses Diagnostic Tests from New Day Diagnostics- SEC Filing

ReutersMay 6, 2025 1:28 PM

- Hepion Pharmaceuticals Inc HEPA.O:

  • HEPION PHARMACEUTICALS - ON APRIL 30, ENTERED INTO BINDING LOI IN-LICENSES DIAGNOSTIC TESTS FROM NEW DAY DIAGNOSTICS - SEC FILING

  • HEPION PHARMACEUTICALS INC - TO PAY $525,000 CASH AND $200,000 IN STOCK TO NEW DAY - SEC FILING

  • HEPION PHARMACEUTICALS INC - AGREES TO PAY UP TO $17.15 MILLION UPON MILESTONE ACHIEVEMENT - SEC FILING

  • HEPION PHARMACEUTICALS INC - TO PAY ROYALTIES IN UPPER SINGLE TO LOW DOUBLE DIGITS BASED ON NET SALES- SEC FILING

Source text: [ID:n0001641172-25-008761]

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI